RxDoctor Payments Data

Sarah Justmann

Psychiatric/Mental Health · Dubuque, IANPI 1407806128

Payments from drug & device makers

$2,002in general payments, 2019–2025

Across 114 payments — averaging $17.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$266
  • Teva Pharmaceuticals USA, Inc.$248
  • Otsuka America Pharmaceutical, Inc.$221
  • Axsome Therapeutics, Inc.$174
  • Alkermes, Inc.$173
  • Supernus Pharmaceuticals, Inc.$114
  • plus $806 from 17 others

What the payments were for

  • Food & beverage$2,002100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,002 in reported general payments places this provider in the 70th percentile of 443 psychiatric/mental health providers in Iowa.

See all psychiatric/mental health providers in Iowa

Medicare billing

Part B allowed, 2024
$39,191
Medicare patients
193
Services billed
534

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate23$184,786
Invega SustennaPaliperidone Palmitate36$128,722
Austedo XrDeutetrabenazine24$115,125
VraylarCariprazine Hcl62$72,717
Aripiprazole361$37,915
Desvenlafaxine Succinate ErDesvenlafaxine Succinate198$12,204
Paliperidone ErPaliperidone63$10,984
TrintellixVortioxetine Hydrobromide18$10,122
VyvanseLisdexamfetamine Dimesylate21$8,292
Methylphenidate ErMethylphenidate Hcl43$7,616
Divalproex Sodium ErDivalproex Sodium65$7,085
Lisdexamfetamine Dimesylate31$6,988
Lamotrigine ErLamotrigine12$6,911
BelsomraSuvorexant11$4,674
Quetiapine Fumarate343$4,592

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$80$184,78623 claims
Johnson & JohnsonInvega Sustenna$91$128,72236 claims
Teva Pharmaceuticals USA, Inc.Austedo Xr$248$115,12524 claims
AbbVieVraylar$266$72,71762 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$48$18,41539 claims
Lilly USA, LLCOlanzapine$22$3,53390 claims
Almatica Pharma LLCSertraline Hcl$29$1,928248 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 443 psychiatric/mental health providers in Iowa.

Other psychiatric/mental health in Dubuque

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →